are escaping to South Korea every year. The aims of this study is to identify the characteristics of latent tuberculosis infection (LTBI) test results of North Korean refugees and to confirm the actual status of LTBI treatment for North Korean refugees. . The mean size of TST was 17 AE 4 mm and the number of subjects with BCG scar was 122 (70.9%). The mean TST size in males was 14 AE 4 mm and 18 AE 4 mm in females and was statistically significant when BCG scar and age were corrected. (P < 0.001). The Quantiferon Gold in Tube (QFT-GIT) was performed in 103 of the TST positive reactors and all 103 patients were positive. All 172 patients with LTBI were treated with isoniazid and rifampin. Of these, 55 (32.0%) discontinued treatment; one of them (0.6%) was pregnant and three (1.7%) due to adverse events. Thus 117 (68%) completed the LTBI treatment.
Conclusion:
We could detect LTBI based on TST for North Korean refugees and completion rate of LTBI treatment was 68% in North Korean refugees. Further comparative studies with South Korean patients for LTBI and treatment are needed in the future. Results: This study found that total 416 patients was suspected MDR TB. Confirmed MDR TB was 33 (7,93%) patients, consist of new cases (primary) of resistance to rifampicin in 3 (9,1%) patients and previously treated (secondary) MDR TB in 30 (90,9%) patients. Those patients were treated as MDR TB patients with standardized regiment. The average of age MDR TB patients was 3 AE 1,98 years old and most of them were males 23 (69,69%). The risk factor of MDR TB mostly was relapse cases in 22 (66,67%) patients. From three primary MDR TB patients, two of them had diabetic mellitus and one has contact with confirmed MDR TB patients.
